Growth inhibition of human breast cancer cells with an iron chelator and a dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor

被引：0
|
作者：
Witters, Lois
Anyanwu, Uchechi
Nick, Hanspeter
Hackl, Wolfgang
Lipton, Allan
机构：
[1] Penn State Univ, Coll Med, Hershey, PA USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
CANCER RESEARCH | 2009年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2818
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Inhibition of the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway in hematologic malignancies
    Witzig T.E.
    Kaufmann S.H.
    Current Treatment Options in Oncology, 2006, 7 (4) : 285 - 294
  • [2] Dual inhibition of phosphatidylinositol 3-kinase/Akt and mammalian target of rapamycin signaling in human nonsmall cell lung cancer cells by a dietary flavonoid fisetin
    Khan, Naghma
    Afaq, Farrukh
    Khusro, Fatima H.
    Adhami, Vaqar Mustafa
    Suh, Yewseok
    Mukhtar, Hasan
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (07) : 1695 - 1705
  • [3] Mammalian Target of Rapamycin, Akt, and Phosphatidylinositol 3-Kinase Signaling
    Pal, Sumanta K.
    Reckamp, Karen L.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S487 - S489
  • [4] Antitumor Efficacy Profile of PKI-402, a Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor
    Mallon, Robert
    Hollander, Irwin
    Feldberg, Larry
    Lucas, Judy
    Soloveva, Veronica
    Venkatesan, Aranapakam
    Dehnhardt, Christoph
    Delos Santos, Efren
    Chen, Zecheng
    dos Santos, Osvaldo
    Ayral-Kaloustian, Semiramis
    Gibbons, Jay
    MOLECULAR CANCER THERAPEUTICS, 2010, 9 (04) : 976 - 984
  • [5] Pharmacologic characterization of SHR8443, a novel dual inhibitor of phosphatidylinositol 3-kinase and mammalian target of rapamycin
    Xie, Chengying
    Chen, Xiangling
    Zheng, Mingyue
    Liu, Xiaohong
    Wang, Hongbin
    Lou, Liguang
    ONCOTARGET, 2017, 8 (64) : 107977 - 107990
  • [6] Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-β1 in prostate cancer cells
    Van der Poel, HG
    JOURNAL OF UROLOGY, 2004, 172 (04): : 1333 - 1337
  • [7] Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?
    Dominique S Meyer
    Mohamed Bentires-Alj
    Breast Cancer Research, 12
  • [8] Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?
    Meyer, Dominique S.
    Bentires-Alj, Mohamed
    BREAST CANCER RESEARCH, 2010, 12 (05):
  • [9] Autophagy inhibition enhances colorectal cancer apoptosis induced by dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235
    Yang, Xiaoyu
    Niu, Bingxuan
    Wang, Libo
    Chen, Meiling
    Kang, Xiaochun
    Wang, Luonan
    Ji, Yinghua
    Zhong, Jiateng
    ONCOLOGY LETTERS, 2016, 12 (01) : 102 - 106
  • [10] Inhibition of Autophagy as a Strategy to Augment Radiosensitization by the Dual Phosphatidylinositol 3-Kinase/Mammalian Target of Rapamycin Inhibitor NVP-BEZ235
    Cerniglia, George J.
    Karar, Jayashree
    Tyagi, Sonia
    Christofidou-Solomidou, Melpo
    Rengan, Ramesh
    Koumenis, Constantinos
    Maity, Amit
    MOLECULAR PHARMACOLOGY, 2012, 82 (06) : 1230 - 1240
12345